LuciTala

药品简介

Originator: Talzenna by Pfizer · Manufacturer: Lucius Pharma. Indication & Dosage: LuciTala (Talazoparib), generic Talzenna is a prescription medicine used to treat of adult patients with deleterious or suspected deleterious BRCA-mutated (gBRCAm) HER2-negative advanced or metastatic breast cancer. It is a single agent. Talazoparib is a poly (ADP-ribose) polymerase (PARP) inhibitor. Talazoparib in combination with Enzalutamide for the treatment of adult patients with HRR gene-mutated metastatic castration-resistant prostate cancer (mCRPC). LuciTala manufactured by Lucius Pharma Ltd. in Laos. Recommended Dosage for gBRCAm HER2-negative Locally Advanced or Metastatic Breast Cancer: • The recommended dosage of Talazoparib is 1 mg taken orally once daily with or without food until disease progression or unacceptable toxicity. • For adverse reactions, dosing interruption or dose reduction should be considered. Recommended Dosage for HRR Gene-mutated mCRPC: • The recommended Side Effects: The most common adverse reactions of Talazoparib are: Blood cell disorders, Tiredness, High blood sugar, Changes in liver function tests, Low calcium levels, also called hypocalcemia, Nausea and vomiting, Headache, Hair loss, Diarrhea, Loss of appetite. The above information comes from the Internet. Please consult with doctor for medical advice.

本信息仅供参考，不构成医疗建议。请务必咨询合格的医疗专业人士。